Zapping the brain to boost memory and sleep in seniors
NCT ID NCT07433738
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a gentle, non-invasive brain stimulation technique called so-tDCS in 80 older adults who have mild memory and sleep complaints. Participants will receive either real or sham stimulation over 4 weeks. Researchers will track changes in memory, sleep quality, and brain health markers to see if this approach can help.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- High-definition slow-oscillatory transcranial direct current stimulation (so-tDCS) – a gentle, non-invasive brain stimulation device
- What this could lead to
- If it works, this could offer a safe, non-drug way to ease memory and sleep problems in older adults, potentially slowing cognitive decline.
- What could go wrong
- This is an early-stage trial with only 80 participants, so results may not apply to everyone. The effect may be small or temporary, and individual responses vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLEEP are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tai Po Hospital
Hong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A 45-Minute lesson could sharpen Students' minds and sleep
- Can a sleepless night rewire hunger and memory?
- Melatonin bath products: are they absorbed like pills?
- Can a strange bed sabotage your workout? sex differences put to the test
- Can your pupils reveal the secrets of sleep and body clocks?
- Can fish oil calm ADHD and autism symptoms? a new trial investigates